BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3260692)

  • 1. [HLA antigens in patients with Sjögren's syndrome].
    Moutsopoulos HM; Papasteriades CA; Skopouli FN; Drosos AA
    Ter Arkh; 1988; 60(4):28-30. PubMed ID: 3260692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-alloantigen associations in Greek patients with Sjögren's syndrome.
    Papasteriades CA; Skopouli FN; Drosos AA; Andonopoulos AP; Moutsopoulos HM
    J Autoimmun; 1988 Feb; 1(1):85-90. PubMed ID: 3151145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
    Whittingham S; Mackay IR; Tait BD
    Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to Ro(SSA) and La(SSB) antigens in Sjögren's disease and syndrome].
    Kirtava ZZ; Guseva NG
    Revmatologiia (Mosk); 1987; (2):44-50. PubMed ID: 3313638
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of HLA-B8 and HLA-DR3 in Japanese patients with Sjögren's syndrome positive for anti-SSA(Ro).
    Miyagawa S; Dohi K; Shima H; Shirai T
    J Rheumatol; 1992 Dec; 19(12):1922-4. PubMed ID: 1294741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
    Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
    Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
    Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
    Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome.
    Pease CT; Shattles W; Charles PJ; Venables PJ; Maini RN
    Clin Exp Rheumatol; 1989; 7(2):185-90. PubMed ID: 2786788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
    Ricchiuti V; Isenberg D; Muller S
    J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of anti-Ro and anti-La antigen antibodies in Sjögren's disease and syndrome].
    Kirtava ZZ; Guseva NG; Simonova MV; Lekakh IV; Poverennyĭ AM
    Ter Arkh; 1988; 60(4):21-5. PubMed ID: 3260690
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
    Provost TT; Watson R
    J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome.
    Bolstad AI; Wassmuth R; Haga HJ; Jonsson R
    J Rheumatol; 2001 Jul; 28(7):1554-62. PubMed ID: 11469461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody repertoire to Ro/SSA and La/SSB antigens in patients with primary and secondary Sjögren's syndrome.
    Wahren M; Solomin L; Pettersson I; Isenberg D
    J Autoimmun; 1996 Aug; 9(4):537-44. PubMed ID: 8864830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules.
    Paisansinsup T; Deshmukh US; Chowdhary VR; Luthra HS; Fu SM; David CS
    J Immunol; 2002 Jun; 168(11):5876-84. PubMed ID: 12023392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
    Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
    J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
    Helsloot J; Sturgess A
    J Rheumatol; 1997 Dec; 24(12):2340-7. PubMed ID: 9415639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.
    Pease CT; Charles PJ; Shattles W; Markwick J; Maini RN
    Br J Rheumatol; 1993 Jul; 32(7):574-7. PubMed ID: 8339127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of anti-SSA and anti-SSB antibodies and its clinical significance].
    Wu DH
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):194-6. PubMed ID: 6432277
    [No Abstract]   [Full Text] [Related]  

  • 19. The anti-Ro antibody system.
    Hymes SR; Russell TJ; Jordon RE
    Int J Dermatol; 1986; 25(1):1-7. PubMed ID: 3512458
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.
    Moutsopoulos HM; Zerva LV
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):123-30. PubMed ID: 2203591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.